Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK

Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK

Submitted by CP Staff on June 15, 2018 - 9:37am
Source: 
Endpoints
News Tags: 
Bristol-Myers Squibb
Opdivo
China
Headline: 
Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK
snippet: 

Bristol-Myers’ $BMY Opdivo may be about to cede its top place in the PD-1/L1 world to Merck, but in China today, they’re number 1.

Do Not Allow Advertisers to Use My Personal information